[1]
S. C. Lee MW, “Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor”, Acta Derm Venereol, vol. 84, no. 1, pp. 23–26, Mar. 2004.